Ubs Oconnor LLC Horizon Therapeutics Public LTD CO Transaction History

Ubs Oconnor LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $365 Million - $426 Million	3,684,638 Added 92.59%	7,664,245 $887 Million
Q2 2023 Feb 14, 2024	BUY	$96.34 - $112.38 $197 Million - $230 Million	2,045,477 Added 89.49%	4,331,267 $445 Billion
Q1 2023 Nov 14, 2023	BUY	$107.32 - $113.5 $427 Million - $452 Million	3,979,607 New	3,979,607 $434 Billion
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.41 Million - $1.49 Million	13,125 New	13,125 $1.43 Million
Q4 2022 Feb 14, 2024	SELL	$62.39 - $113.8 $336 Million - $612 Million	-5,378,455 Reduced 70.18%	2,285,790 $260 Billion

Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $294,600 - $423,350	-5,000 Reduced 6.3%	74,347 $4.6 Billion
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $4.32 Million - $6.32 Million	54,347 Added 217.39%	79,347 $6.33 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $2.16 Million - $2.75 Million	25,000 New	25,000 $2.63 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.